The Global MedTech Market – Facts – Opportunities – Market Shares

In 2019, global medical technology sales were $ 450 billion growing by 5.2% p.a.

Despite the modest, general growth, there are always business areas that are growing at 45% p.a. One example is trans-catheter heart valves with a growth rate of 42% p.a. (Edwards LifeSciences, 2011-2016), another is infrared fluorescence imaging to display tissue perfusion with 49% p.a. (Novadaq, 2011-2016).

There is also a healthy basis for continued growth: The aging of the population, e.g. in the U.S 3.1% more citizens over 65 years of age per year. In addition, there are the Megatrends that are driving case numbers.

Market Segments

In-vitro diagnostics is the largest sector, followed by cardiology and diagnostic imaging. The graph implies a market growth of 5.6% p.a.

The economic burden of heart disease amounts to around 300 billion Dollars in the U.S.A. and 300 billion Euros in the EU. In the U.S., 60% of this is direct costs compared to  50% in Europe.

Growth Drivers: Megatrends

  • Aging societies (U.S.: 3.1% more retirees 65y+ per year)
  • Change in the spectrum of diseases
  • Higher incidences
  • More chronic diseases (Diabetes, Obesity, Coronary Heart Disease, COPD, Dementia)
  • Limitation of the health budget (17.7% of the U.S. gross domestic product, 11.9% in Germany)
  • Correlation of social status and life expectancy (in London 2015: 10 years)
  • Mobility
  • Independent living


There’s a lot of money involved, as the market capitalization of the big players shows:

Ethicon / J&J$422bFesenius Medical Care$24.4b
Boston Scientific$51.5bSiemens Healthineers.$96.7b
Abbott Laboratories$199bCardinal Health.$16.2b
Philips Healthcare$49.7bStryker$90.9b
Medtronic Plc$157bDePuy Synthesn/a
Baxter International Inc.$40.9bBecton Dickinson$76.3b
GE Healthcare$99.2b$b = $Mrd.

and substantial profits

CompaniesSalesCross marginEBITEBITDA
Johnson & Johnson$82.1b66.4%21.5%30.4%
Boston Scientific$10.7b71.0%10.8%25.9%

In the U.S.A., the EBIT of public MedTech companies is around 20%, in Germany that of electro-medical companies 16% and that of industry 8.1% *⁴

Global Transaktions*5

With a total of 7,377 transactions in 2017/18, healthcare is at the top with 491 takeovers and 606 VC investments.

56% of the value of global M&A transactions is in the U.S., while it is 13% in the EU

European MedTech Patents*⁶

MedTech is an extremely agile market, not just when it comes to acquisitions. In terms of patent approval, MedTech and Digital lead the way – in the previous year, the positions were reversed.

German MedTech*⁷

  • 212,000 jobs
  • 500.000 products
  • Revenue: 30.3 Mrd€
  • Export rate: 65%
  • With 10%, Germany has the second largest global market share after the U.S.
  • German expenditures for MedTech: 36 Mrd€
  • Corporations and firms:
    • 90 MedTech firms with more than 250 employees
    • 13.000 small enterprises with 60.000 employees

To summarize: with its outstanding growth opportunities and enormous profitability, there are still treasures to be found in the medical technology market!


  1. Precedence Research «Medical Devices Market — Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2020 — 2027»
  2. Evaluate MedTech, «World Preview 2018, Outlook to 2024»
  3. Yahoo Finance 18.01.2021 / 21
  4. Hans Böckler Stiftung, «Branchenanalyse Medizintechnik», Mai 2020
  5. Deloitte 2019 «Small Gains, Big Wins»
  6. «European MedTech Industry in Figures 2020»*6:
  7. «BVMed Branchenbericht 2020»

Zum Kontaktformular